Literature DB >> 8986714

Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation.

J H Wang1, A Nichogiannopoulou, L Wu, L Sun, A H Sharpe, M Bigby, K Georgopoulos.   

Abstract

Mice homozygous for an Ikaros null mutation display distinct defects in the development of fetal and adult lymphocytes. Fetal T lymphocytes, and fetal and adult B lymphocytes and their earliest progenitors are absent. Postnatally, hematopoietic stem cells give rise to thymocyte precursors that undergo aberrant differentiation into the CD4 lineage and clonal expansion. The lack of NK cells and some gamma delta T cell subsets and a large reduction in thymic dendritic APCs suggest that Ikaros is essential for establishing early branch points in the postnatal T cell pathway. The lymphoid defects detected in Ikaros null mice reveal critical molecular differences between fetal and postnatal hematopoietic progenitors that dictate their ability to give rise to T cells. These studies also establish Ikaros as a tumor suppressor gene acting during thymocyte differentiation. Phenotypic comparison of this null mutation with a severe dominant-negative Ikaros mutation identifies molecular redundancy in the postnatal hemolymphoid system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8986714     DOI: 10.1016/s1074-7613(00)80269-1

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  196 in total

1.  Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes.

Authors:  J Koipally; A Renold; J Kim; K Georgopoulos
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

Review 2.  Disorderly conduct in gammadelta versus alphabeta T cell lineage commitment.

Authors:  Kavitha Narayan; Joonsoo Kang
Journal:  Semin Immunol       Date:  2010-05-06       Impact factor: 11.130

3.  Helios transcription factor expression depends on Gsx2 and Dlx1&2 function in developing striatal matrix neurons.

Authors:  Raquel Martín-Ibáñez; Empar Crespo; Miriam Esgleas; Noelia Urban; Bei Wang; Ronald Waclaw; Katia Georgopoulos; Salvador Martínez; Kenneth Campbell; Carlos Vicario-Abejón; Jordi Alberch; Susan Chan; Philippe Kastner; John L Rubenstein; Josep M Canals
Journal:  Stem Cells Dev       Date:  2012-01-26       Impact factor: 3.272

Review 4.  Insights into T-cell development from studies using transgenic and knockout mice.

Authors:  M A Basson; R Zamoyska
Journal:  Mol Biotechnol       Date:  2001-05       Impact factor: 2.695

5.  Phosphorylation controls Ikaros's ability to negatively regulate the G(1)-S transition.

Authors:  Pablo Gómez-del Arco; Kazushige Maki; Katia Georgopoulos
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

6.  The innate side of TOX.

Authors:  James P Di Santo
Journal:  Nat Immunol       Date:  2010-10       Impact factor: 25.606

7.  Genome-wide identification of TAL1's functional targets: insights into its mechanisms of action in primary erythroid cells.

Authors:  Mira T Kassouf; Jim R Hughes; Stephen Taylor; Simon J McGowan; Shamit Soneji; Angela L Green; Paresh Vyas; Catherine Porcher
Journal:  Genome Res       Date:  2010-06-21       Impact factor: 9.043

8.  Ikaros promotes early-born neuronal fates in the cerebral cortex.

Authors:  Jessica M Alsiö; Basile Tarchini; Michel Cayouette; Frederick J Livesey
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

9.  Ikaros imposes a barrier to CD8+ T cell differentiation by restricting autocrine IL-2 production.

Authors:  Shaun O'Brien; Rajan M Thomas; Gerald B Wertheim; Fuqin Zhang; Hao Shen; Andrew D Wells
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

10.  Fingerprinting ikaros.

Authors:  Fotini Gounari; Barbara L Kee
Journal:  Nat Immunol       Date:  2013-10       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.